Press Releases

22 Sep 2021
Clinigen signs European agreement with Secura Bio for the exclusive supply and distribution of COPIKTRA
Related materials
PDF (201.79KB)
16 Sep 2021
Full Year results for the year ended 30 June 2021
Related materials
PDF (664.26KB) Presentation Listen to the webcast
02 Sep 2021
Clinigen signs exclusive UK supply and distribution agreement with PAION
Related materials
PDF (216.83KB)
01 Sep 2021
Board Update
Related materials
PDF (204.88KB)
25 Aug 2021
Board Change
Related materials
PDF (191.71KB)
05 Aug 2021
Removal of Erwinase® (crisantaspase) supply constraints in the United Kingdom
Related materials
PDF (140.10KB)
05 Aug 2021
Clinigen signs exclusive agreement with Eyevance Pharmaceuticals to supply and distribute NATACYN® (natamycin) in several markets outside the US
Related materials
PDF (214.65KB)
03 Aug 2021
Clinigen Board Changes
Related materials
PDF (261.67KB)
21 Jul 2021
Clinigen and ORPHELIA Pharma sign an exclusive agreement to supply Kigabeq® (vigabatrin)
Related materials
PDF (206.12KB)
20 Jul 2021
Clinigen and Horizon Therapeutics to launch Managed Access Program for UPLIZNA® (inebilizumab-cdon)
Related materials
PDF (221.43KB)